Tag archive for ‘Mylan Inc’
(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Gali Raz On Friday, October 30th, 2015

U.S. Court Denies Perrigo’s Attempt to Block Mylan’s Takeover Bid

Mylan N.V., which made a hostile takeover bid for Perrigo Co., said Friday that a U.S. District court denied Perrigo’s attempt to block the potential closing of Mylan’s proposed offer before shareholders. The More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Niva Goldberg On Thursday, October 22nd, 2015

Perrigo Taking Actions To Fend off Mylan, Deliver Shareholder Value Far Superior To Mylan Offer

Perrigo, which is the target of a hostile takeover bid by Mylan, said Thursday that it would reduce its workforce by approximately 800 employees, or approximately 6 percent of its current global More...

Niva Goldberg On Sunday, July 26th, 2015

Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ

Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...

Niva Goldberg On Tuesday, July 7th, 2015

Three Way Takeover Battle: Teva plans raising Mylan bid to $43 billion – report

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), the Israeli drugmaker, is preparing to improved proposal for US rival Mylan to as much as $43 billion, $86 to $88 a share, as soon as this More...

Shiri Habib-Valdhorn On Wednesday, July 1st, 2015

Teva CEO: The industry is undergoing a shakeup

“Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the company’s strategic direction and contribute More...

Niva Goldberg On Thursday, June 18th, 2015

U.S. court invalidates Teva’s Copaxone patent

The U.S. Court of Appeals has again ruled that Teva Pharmaceuticals Industries Ltd.’s patent for its top-selling multiple sclerosis treatment Copaxone is invalid. A Teva spokeswoman said that the company is More...

Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Teva’s Mylan stake up to 4.3%

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) continues to accumulate shares in takeover target Mylan (MYL), even as Mylan’s largest shareholder, Abbott Labs (NYSE: ABT), announced More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Mylan to list on TASE if Perrigo bid succeeds

  One of the main worries of Tel Aviv Stock Exchange (TASE) leaders recently has been the expected delisting of Perrigo Company (NYSE:PRGO; TASE:PRGO), if and when the company’s acquisition by Mylan More...

Shiri Habib-Valdhorn On Monday, June 15th, 2015

Three Way Takeover Battle: Statistics weigh against Teva’s Mylan bid succeeding

  Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover More...

Clive Minchom On Monday, June 8th, 2015

Teva Issues New Letter to Mylan NV Confirming Seriousness Of Offer To Acquire Mylan

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) issued a new open letter on Monday, signed by both the Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, addressed to More...

Wordpress site Developed by Fixing WordPress Problems